WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
Written by Emily J. Thompson, Senior Investment Analyst
Source: WSJ
WuXi Biologics Sells Vaccine Facility: WuXi Biologics has agreed to sell its vaccine manufacturing plant in Dundalk, Ireland, to Merck & Co. for approximately $500 million, aiming to enhance its cash flow and margins amid global uncertainties.
Details of the Transaction: The facility, valued at about $487 million, spans 15,520 square meters and employs 200 staff members; the sale is expected to finalize in the first half of 2025.
Analyst Views on C
Wall Street analysts forecast C stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for C is 125.50 USD with a low forecast of 87.00 USD and a high forecast of 146.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
13 Buy
3 Hold
0 Sell
Strong Buy
Current: 115.660
Low
87.00
Averages
125.50
High
146.00
Current: 115.660
Low
87.00
Averages
125.50
High
146.00
About C
Citigroup Inc. is a global diversified financial services holding company. The Company’s segments include Services, Markets, Banking, Wealth and U.S. Personal Banking (USPB). The Services segment includes Treasury and Trade Solutions (TTS) and securities services. TTS provides an integrated suite of tailored cash management, trade and working capital solutions to multinational corporations, financial institutions and public sector organizations. The Markets segment provides corporate, institutional and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products and commodities. The Banking segment includes investment banking, which supports client capital-raising needs to help strengthen and grow their businesses. The Wealth segment includes Private Bank, Wealth at Work and Citigold and provides financial services to a range of client segments. USPB segment includes branded cards and retail services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
